Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 4.65
(1.09%)
CNY 4.65
(1.09%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 18.16 Million CNY | -69.28% |
| 2022 | 59.13 Million CNY | -25.42% |
| 2021 | 79.28 Million CNY | 23.95% |
| 2020 | 63.96 Million CNY | 13.22% |
| 2019 | 56.49 Million CNY | -51.65% |
| 2018 | 116.86 Million CNY | -29.61% |
| 2017 | 166 Million CNY | 10.85% |
| 2016 | 149.76 Million CNY | 9.64% |
| 2015 | 136.6 Million CNY | -18.04% |
| 2014 | 166.67 Million CNY | -29.51% |
| 2013 | 236.45 Million CNY | -4.06% |
| 2012 | 246.45 Million CNY | 103.68% |
| 2011 | 121 Million CNY | 70.9% |
| 2010 | 70.8 Million CNY | 183.2% |
| 2009 | 25 Million CNY | 400.0% |
| 2008 | 5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 4.46 Million CNY | -92.46% |
| 2024 Q1 | 7.91 Million CNY | -56.44% |
| 2024 Q2 | 15.99 Million CNY | 102.12% |
| 2023 Q2 | 12.67 Million CNY | -21.75% |
| 2023 Q3 | 9.06 Million CNY | -28.46% |
| 2023 Q4 | 18.16 Million CNY | 100.35% |
| 2023 Q1 | 16.19 Million CNY | -72.61% |
| 2023 FY | 18.16 Million CNY | -69.28% |
| 2022 Q3 | 62.94 Million CNY | -0.63% |
| 2022 Q1 | 76.7 Million CNY | -3.26% |
| 2022 FY | 59.13 Million CNY | -25.42% |
| 2022 Q4 | 59.13 Million CNY | -6.05% |
| 2022 Q2 | 63.34 Million CNY | -17.43% |
| 2021 Q1 | 39.38 Million CNY | -38.43% |
| 2021 Q4 | 79.28 Million CNY | 157.51% |
| 2021 Q2 | 33.96 Million CNY | -13.76% |
| 2021 Q3 | 30.79 Million CNY | -9.34% |
| 2021 FY | 79.28 Million CNY | 23.95% |
| 2020 Q2 | 64.3 Million CNY | -0.31% |
| 2020 FY | 63.96 Million CNY | 13.22% |
| 2020 Q4 | 63.96 Million CNY | -0.52% |
| 2020 Q1 | 64.49 Million CNY | 14.16% |
| 2020 Q3 | 64.3 Million CNY | 0.0% |
| 2019 Q3 | 86.63 Million CNY | -10.19% |
| 2019 Q2 | 96.45 Million CNY | 0.0% |
| 2019 Q1 | 96.45 Million CNY | -17.46% |
| 2019 FY | 56.49 Million CNY | -51.65% |
| 2019 Q4 | 56.49 Million CNY | -34.78% |
| 2018 Q2 | 128.62 Million CNY | 1.23% |
| 2018 FY | 116.86 Million CNY | -29.61% |
| 2018 Q4 | 116.86 Million CNY | -6.56% |
| 2018 Q3 | 125.05 Million CNY | -2.78% |
| 2018 Q1 | 127.06 Million CNY | -23.46% |
| 2017 Q2 | 146.83 Million CNY | -4.37% |
| 2017 Q4 | 166 Million CNY | 19.23% |
| 2017 Q3 | 139.23 Million CNY | -5.18% |
| 2017 FY | 166 Million CNY | 10.85% |
| 2017 Q1 | 153.54 Million CNY | 2.52% |
| 2016 Q1 | 128.9 Million CNY | -5.64% |
| 2016 Q4 | 149.76 Million CNY | 11.87% |
| 2016 Q3 | 133.86 Million CNY | 0.73% |
| 2016 Q2 | 132.9 Million CNY | 3.1% |
| 2016 FY | 149.76 Million CNY | 9.64% |
| 2015 Q1 | 186.02 Million CNY | 11.61% |
| 2015 Q2 | 186.02 Million CNY | 0.0% |
| 2015 Q3 | 125.56 Million CNY | -32.5% |
| 2015 FY | 136.6 Million CNY | -18.04% |
| 2015 Q4 | 136.6 Million CNY | 8.79% |
| 2014 Q4 | 166.67 Million CNY | -23.88% |
| 2014 Q3 | 218.95 Million CNY | -3.84% |
| 2014 FY | 166.67 Million CNY | -29.51% |
| 2014 Q1 | 227.7 Million CNY | -3.7% |
| 2014 Q2 | 227.7 Million CNY | 0.0% |
| 2013 Q1 | 246.45 Million CNY | 0.0% |
| 2013 Q4 | 236.45 Million CNY | -4.06% |
| 2013 Q3 | 246.45 Million CNY | 0.0% |
| 2013 Q2 | 246.45 Million CNY | 0.0% |
| 2013 FY | 236.45 Million CNY | -4.06% |
| 2012 Q1 | 173.5 Million CNY | 43.39% |
| 2012 Q2 | 170.82 Million CNY | -1.54% |
| 2012 FY | 246.45 Million CNY | 103.68% |
| 2012 Q3 | 224.38 Million CNY | 31.36% |
| 2012 Q4 | 246.45 Million CNY | 9.83% |
| 2011 Q4 | 121 Million CNY | 0.0% |
| 2011 Q2 | 49.8 Million CNY | 0.0% |
| 2011 FY | 121 Million CNY | 70.9% |
| 2010 FY | 70.8 Million CNY | 183.2% |
| 2009 FY | 25 Million CNY | 400.0% |
| 2008 FY | 5 Million CNY | 0.0% |